CD274 and breast carcinoma: By contrast, tumor cell-intrinsic PD-L1 contributes to the EMT phenotype and tumor progression in melanoma, ovarian cancer, breast cancer, nasopharyngeal carcinoma, and lung cancer [12, 14, 27, 28].